National Health Investors cuts target price to $65 from $68
NHI•Wells Fargo cut its target price for National Health Investors to $65 from $68.
Related News

BTQ Technologies clarifies Q3 2026 results call set for Nov. 17 at 11 a.m. EST
BTQ•

Zymeworks Chief Scientific Officer Paul Andrew Moore sells $1.04 million in common shares
ZYME•

Revolution Medicines, Inc.: Needham cuts target price to $273 from $275
RVMD•

Alpha Tau reports 100% response rate in six evaluable patients in recurrent glioblastoma trial
DRTS•

Stronger dollar, AI investment worries push copper to four-month low
XLB•